查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
乳癌治疗市场规模和预测、全球和区域份额、趋势和成长机会分析报告范围：按药物治疗、乳癌类型、配销通路和地理位置
市场调查报告书
商品编码
1372542

乳癌治疗市场规模和预测、全球和区域份额、趋势和成长机会分析报告范围：按药物治疗、乳癌类型、配销通路和地理位置

Breast Cancer Therapeutics Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy, Breast Cancer Type, Distribution Channel, and Geography
出版日期: | 出版商: The Insight Partners | 英文 204 Pages | 订单完成后即时交付

价格

乳癌治疗市场规模和预测（2020-2030）、全球和地区份额、趋势和成长机会分析

承保范围：药物治疗[标靶药物治疗（Abemaciclib、Ado-Trastuzumab Emtansine、Palbociclib、曲妥珠单抗和其他标靶药物治疗）、荷尔蒙药物治疗（选择性雌激素受体调节剂、芳香酶抑制剂和选择性雌激素受体下调剂）、化疗和免疫治疗/生物治疗]、乳癌类型（荷尔蒙受体、HER2+和三阴性乳癌）、配销通路（医院药房、药房和零售药房、网路药房）以及地理位置（北美洲、欧洲、亚太地区、中东和非洲、南美洲和中美洲）

乳癌治疗市场规模预计将从2022年的310.7352亿美元成长到2030年的639.6705亿美元；预计2022年至2030年复合年增长率为9.4%。

乳癌是指乳房细胞增生失控。乳癌有多种形式。哪些乳腺细胞发展成癌症决定了乳癌的类型。导管或小叶是大多数乳癌的起始部位。血管和淋巴管是乳癌转移到乳房外的两种方式。其治疗取决于癌症的阶段。它可能包括化疗、放疗、荷尔蒙治疗和手术。乳癌治疗市场的成长归因于乳癌负担的增加以及多项诊断和筛检计画的推出。

个人化医疗涉及根据个别患者的基因组成等因素制定治疗计划。这种方法考虑到每位患者癌症的独特特征，因此可以实现高度针对性和有效的治疗。基因组学和分子诊断的进步使个人化医疗成为乳癌治疗的可行选择。医疗保健提供者可以透过在分子层面分析患者的肿瘤来识别驱动癌症生长的特定基因突变或生物标记。然后可以使用这些资讯来选择最合适的治疗方案，例如可能对特定患者最有效的标靶疗法或免疫疗法。在乳癌治疗中使用个人化医疗有可能显着改善患者的治疗效果。例如，2022 年2 月，NIH 研究人员开发了一种个人化乳癌治疗方法，这是一种实验形式的免疫疗法，利用患者的抗肿瘤免疫细胞来治疗转移性乳癌患者，从而推进个人化医疗。

透过为个别患者提供量身定制的治疗，医疗保健提供者可以增加成功结果的可能性并降低不必要的副作用的风险。除了改善患者的治疗效果外，个人化医疗还可以带来经济效益。透过选择更有可能有效的治疗方法，医疗保健提供者可以减少与无效治疗相关的医疗费用，并避免不必要的费用。随着基因组学和分子诊断的进步，个人化医疗可能在未来几年变得越来越容易获得并融入标准治疗方案。因此，个人化医疗的日益普及预计将为乳癌治疗市场带来新的成长趋势。

基于配销通路的见解

根据配销通路，乳癌治疗市场分为医院药房、药局和零售药房以及网路药房。 2022年，医院药局部门占据最大的市场份额。医院药局在乳癌治疗的管理中发挥着至关重要的作用。他们负责配製和配药、监测药物安全、药物管理、病患教育和其他因素。乳癌是全世界最常见的癌症之一，对有效治疗方法的需求正在稳步增长。医院药局负责购买、储存和分发化疗药物和其他与乳癌相关的治疗药物，以确保患者及时接受正确的治疗。这些药局也有权管理这些药品的库存和储存，确保它们按照严格的规定储存和处理。他们与肿瘤学家和医疗团队的合作确保乳癌患者在整个治疗过程中获得最佳的个人化治疗和全面护理。医院药房在提供及时有效的乳癌治疗方面仍然发挥着重要作用，显着影响患者对抗疾病的结果。

然而，线上药局领域预计在 2022 年至 2030 年期间复合年增长率最高。网路药局提供各种乳癌药物，从化疗药物到支持疗法，通常也提供上门送货服务。确保处方验证和维持监管合规性，线上药局在维护医疗保健系统的完整性方面发挥着至关重要的作用。它们也为喜欢离散购物或因治疗而行动不便的患者提供了便利。它们还使患者能够比较价格并获得更广泛的乳癌治疗选择。透过送货上门和患者支援等服务，线上药局不断发展，改变了乳癌治疗体验，并打破了全球患者的地理障碍。此外，越来越多的患者转向这些药房获取治疗药物，因为它们使用起来更方便，这也推动了该领域的成长。

欧洲是市场第二大主导地区。乳癌是英国常见的癌症。根据英国国家医疗服务体系 (NHS)的资料，大约七分之一的女性在一生中被诊断出罹患乳癌。每年约有 55,000 名女性被诊断出罹患乳癌。

医疗产业对新疗法治疗乳癌患者的更大需求导致了研发投资的增加，从而推动了市场的成长。公司投资研发以保持竞争力并为客户提供尖端和创新产品。 2021 年 10 月，一种新的抗体疗法 Trodelvy 被授权在该国治疗一种名为「三阴性乳癌」的侵袭性癌症。 2021年11月，赛诺菲投资1.8亿美元，与从事四种癌症发现和开发项目的法美AI新创公司Owkin达成新的策略合作，总支付额达9,000万美元。此次合作支持赛诺菲在乳癌、肺癌和多发性骨髓瘤等核心领域开发肿瘤产品组合，以加强临床试验设计并检测疾病和治疗结果的预测生物标记。

义大利政府和国家卫生机构发起了多项乳癌早期发现和治疗措施。这些计划包括为 50-69 岁女性提供免费乳房 X 光检查以及全国性乳癌筛检计划。 In addition, as per the information provided by EURACTIV, the country has witnessed a strong rise in the number of specialized Breast Units, from 84 in 2012 to 173 in 2020. The country's growing number of breast units helps healthcare professionals offer treatment to patients with乳癌.因此，上述因素支持了该地区的市场成长。

美国癌症协会、世界卫生组织 (WHO)、美国国立卫生研究院和美国 FDA 是准备乳癌治疗市场报告时参考的主要和次要来源。

目录

第 1 章：简介

  • Insight Partners 研究报告指南
  • 市场区隔

第 2 章：执行摘要

  • 重要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：乳癌治疗市场格局

  • 概述
  • PEST分析
    • 全球PEST分析

第 5 章：乳癌治疗市场 - 主要产业动态

  • 主要市场驱动因素
    • 乳癌负担日益加重
    • 启动多项诊断和筛检项目
  • 主要市场限制
    • 诊疗费用高
  • 主要市场机会
    • 政府和私人组织增加支持
  • 未来主要趋势
    • 越来越多使用个人化医疗
  • 影响分析：

第 6 章：乳癌治疗市场 - 全球市场分析

  • 乳癌治疗市场收入，2022-2030

第 7 章：全球乳癌治疗市场收入与 2030 年药物治疗预测

  • 概述
  • 2022 年和 2030 年按药物治疗分類的乳癌治疗市场收入份额 (%)
  • 标靶药物治疗
  • 荷尔蒙药物治疗
  • 化疗
  • 免疫疗法/生物疗法

第 8 章：按乳癌类型分類的全球乳癌治疗市场收入和 2030 年预测

  • 概述
  • 2022 年和 2030 年按乳癌类型分類的乳癌治疗市场收入份额 (%)
  • 荷尔蒙受体
  • HER2+（人类表皮生长因子受体2）
  • 三阴性乳癌

第 9 章：按配销通路分類的 2030 年全球乳癌治疗市场收入和预测

  • 概述
  • 2022 年和 2030 年乳癌治疗市场收入份额（按配销通路）（%）
  • 医院药房
  • 药局和零售药局
  • 网路药局

第 10 章：乳癌治疗市场 - 地理分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿联酋
    • 南非
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第 11 章：乳癌治疗市场—产业格局

  • 概述
  • 乳癌治疗市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第 12 章：公司简介

  • Eli Lilly and Co
  • Eisai Co Ltd
  • Novartis AG
  • AstraZeneca Plc
  • Pfizer Inc
  • Gilead Sciences Inc
  • Merck & Co Inc
  • Genentech Inc.
  • Teva Pharmaceutical Industries Ltd
  • Amgen Inc

第 13 章：附录

  • 关于我们
  • 专业术语
Product Code: TIPRE00030059

Breast Cancer Therapeutics Market Size and Forecast (2020-2030), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)

The breast cancer therapeutics market size is expected to grow from US$ 31,073.52 million in 2022 to US$ 63,967.05 million by 2030; it is estimated to record a CAGR of 9.4% during 2022 to 2030.

Breast cancer is when the breast's cells proliferate out of control. Breast cancer comes in several forms. Which breast cells develop into cancer determines the type of breast cancer. The ducts or lobules are where most breast cancers start. Blood and lymph vessels are two ways breast cancer can travel outside the breast. Its treatment depends on the stage of cancer. It may consist of chemotherapy, radiation, hormone therapy and surgery. The breast cancer therapeutics market growth is attributed to the growing burden of breast cancer and launch of several diagnostics and screening programs.

Personalized medicine involves tailoring treatment plans to individual patients on the basis of their genetic makeup, among other factors. This approach allows for highly targeted and effective treatments, as it considers the unique characteristics of each patient's cancer. Advancements in genomics and molecular diagnostics have made personalized medicine a viable option in breast cancer treatment. Healthcare providers can identify specific genetic mutations or biomarkers driving the cancer's growth by analyzing a patient's tumor at a molecular level. This information can then be used to select the most appropriate treatment options, such as targeted therapies or immunotherapies, that are likely to be the most effective for that particular patient. The use of personalized medicine in breast cancer therapeutics has the potential to significantly improve patient outcomes. For instance, in February 2022, NIH researchers developed a personalized breast cancer therapy approach, an experimental form of immunotherapy that uses a patient's tumor-fighting immune cells to treat those with metastatic breast cancer, advancing personalized medicine.

By providing tailored treatments to individual patients, healthcare providers can increase the likelihood of successful outcomes and reduce the risk of unnecessary side effects. In addition to improving patient outcomes, personalized medicine also offers economic benefits. By selecting treatments that are more likely to be effective, healthcare providers can reduce healthcare costs associated with ineffective treatments and avoid unnecessary expenses. As advancements in genomics and molecular diagnostics progress, personalized medicine is likely to become increasingly accessible and integrated into standard treatment protocols in the coming years. Therefore, the increasing use of personalized medicine is anticipated to bring new growth trends in the breast cancer therapeutics market.

Distribution Channel -Based Insights

Based on distribution channel, the breast cancer therapeutics market is segmented into hospital pharmacies, drug stores and retail pharmacies, and online pharmacies. The hospital pharmacies segment held the largest market share in 2022. The hospital pharmacy plays a crucial role in the management of breast cancer therapeutics. They are responsible for compounding and dispensing, monitoring drug safety, medication management, educating patients, and other factors. Breast cancer is one of the most widespread cancers worldwide, and the demand for effective therapeutics is steadily increasing. Hospital pharmacies are responsible for procuring, storing, and dispensing chemotherapy medications and other treatments related to breast cancer to ensure that patients receive the right treatment in time. These pharmacies are also in authority to manage the inventory and storage of these drugs, ensuring that they are stored and handled in accordance with strict regulations. Their collaborative efforts with oncologists and healthcare teams ensure that breast cancer patients receive optimal, personalized therapeutics and comprehensive care throughout their treatment journey. Hospital pharmacies remain instrumental in delivering timely and effective breast cancer treatments, significantly impacting patients' outcomes in battling the disease.

However, the online pharmacies segment is anticipated to register the highest CAGR during 2022-2030. Online pharmacies offer a wide array of breast cancer medications ranging from chemotherapy drugs to supportive therapies, often with home delivery services. Ensuring prescription verification and maintaining regulatory compliance, online pharmacies play a vital role in upholding the integrity of the healthcare system. They also provide convenience for patients who prefer discrete shopping or have limited mobility due to treatment. They also enable patients to compare prices and access a broader selection of breast cancer therapeutics. With services such as home delivery and patient support, online pharmacies continue to evolve, transforming the breast cancer treatment experience and breaking down geographical barriers for patients worldwide. In addition, an increasing number of patients have shifted to these pharmacies to acquire therapeutics due to their greater ease in terms of usage, which is fueling the growth of the segment.

Europe is the second leading region in the market. Breast cancer is a common type of cancer in the UK. As per the National Health Service (NHS), about one in seven women are diagnosed with breast cancer during their lifespan in Great Britain data. Each year, ~55,000 women are diagnosed with breast cancer.

Greater demand from the medical industry to treat breast cancer patients with novel therapeutics has led to greater investment in R&D, fueling the growth of the market. Companies invest in research and development to stay competitive and provide customers with cutting-edge and innovative products. In October 2021, Trodelvy, a new antibody treatment, was authorized to treat an aggressive form of cancer called 'triple-negative breast cancer' in the country. In November 2021, Sanofi invested US$ 180 million and entered into a new strategic collaboration with Owkin, a French-American AI start-up engaged in the discovery and development programs of four types of cancer, with a total payment of US$ 90 million. The collaboration supported Sanofi's developing oncology portfolio in core areas such as breast cancer, lung cancer, and multiple myeloma to enhance clinical trial design and detect predictive biomarkers for diseases and treatment results.

The Italian government and national health institutes have launched several initiatives for the early detection and treatment of breast cancer. These programs include free mammograms for women aged 50-69 and a nationwide breast cancer screening program. In addition, as per the information provided by EURACTIV, the country has witnessed a strong rise in the number of specialized Breast Units, from 84 in 2012 to 173 in 2020. The country's growing number of breast units helps healthcare professionals offer treatment to patients with breast cancer. Thus, the abovementioned factors support the market growth in the region.

The American Cancer S0ociety, World Health Organization (WHO), National Institutes of Health, and US FDA are among the primary and secondary sources referred to while preparing the breast cancer therapeutics market report.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the breast cancer therapeutics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global breast cancer therapeutics market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Breast Cancer Therapeutics Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Global PEST Analysis

5. Breast Cancer Therapeutics Market - Key Industry Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Growing Burden of Breast Cancer
    • 5.1.2 Launch of Several Diagnostics and Screening Programs
  • 5.2 Key Market Restraints
    • 5.2.1 High Cost of Diagnosis and Treatment
  • 5.3 Key Market Opportunities
    • 5.3.1 Increased Support from Government and Private Organizations
  • 5.4 Key Future Trends
    • 5.4.1 Increasing Use of Personalized Medicine
  • 5.5 Impact Analysis:

6. Breast Cancer Therapeutics Market - Global Market Analysis

  • 6.1 Breast Cancer Therapeutics Market Revenue (US$ Mn), 2022 2030

7. Global Breast Cancer Therapeutics Market Revenue and Forecast to 2030 by Drug Therapy

  • 7.1 Overview
  • 7.2 Breast Cancer Therapeutics Market Revenue Share, by Drug Therapy, 2022 & 2030 (%)
  • 7.3 Targeted Drug Therapy
    • 7.3.1 Overview
    • 7.3.2 Targeted Drug Therapy: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
      • 7.3.2.1 Global Breast Cancer Therapeutics Market, by Targeted Drug Therapy, 2020 - 2030 (US$ Million)
  • 7.4 Hormonal Drug Therapy
    • 7.4.1 Overview
    • 7.4.2 Hormonal Drug Therapy: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Chemotherapy
    • 7.5.1 Overview
    • 7.5.2 Chemotherapy: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Immunotherapy/ Biological Therapy
    • 7.6.1 Overview
    • 7.6.2 Immunotherapy/ Biological Therapy: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)

8. Global Breast Cancer Therapeutics Market Revenue and Forecast to 2030 by Breast Cancer Type

  • 8.1 Overview
  • 8.2 Breast Cancer Therapeutics Market Revenue Share, by Breast Cancer Type, 2022 & 2030 (%)
  • 8.3 Hormone Receptor
    • 8.3.1 Overview
    • 8.3.2 Hormone Receptor: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
  • 8.4 HER2+ (human epidermal growth factor receptor 2)
    • 8.4.1 Overview
    • 8.4.2 HER2+: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Triple-Negative Breast Cancer
    • 8.5.1 Overview
    • 8.5.2 Triple-Negative Breast Cancer: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)

9. Global Breast Cancer Therapeutics Market Revenue and Forecast to 2030 by Distribution Channel

  • 9.1 Overview
  • 9.2 Breast Cancer Therapeutics Market Revenue Share, by Distribution Channel, 2022 & 2030 (%)
  • 9.3 Hospital Pharmacies
    • 9.3.1 Overview
    • 9.3.2 Hospital Pharmacies: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Drug Store and Retail Pharmacies
    • 9.4.1 Overview
    • 9.4.2 Drug Store and Retail Pharmacies: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Online Pharmacies
    • 9.5.1 Overview
    • 9.5.2 Online Pharmacies: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)

10. Breast Cancer Therapeutics Market - Geographical Analysis

  • 10.1 North America Breast Cancer Therapeutics Market, Revenue and Forecast To 2030
    • 10.1.1 Overview
    • 10.1.2 North America Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
    • 10.1.3 North America: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
      • 10.1.3.1 North America: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
      • 10.1.3.2 North America: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
    • 10.1.4 North America: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
    • 10.1.5 North America: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
    • 10.1.6 North America Breast Cancer Therapeutics Market, by Country
      • 10.1.6.1 US
        • 10.1.6.1.1 US Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.6.1.2 US: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.1.6.1.2.1 US: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.1.6.1.2.2 US: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.1.6.1.3 US: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
        • 10.1.6.1.4 US: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
      • 10.1.6.2 Canada
        • 10.1.6.2.1 Canada Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.6.2.2 Canada: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.1.6.2.2.1 Canada: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.1.6.2.2.2 Canada: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.1.6.2.3 Canada: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
        • 10.1.6.2.4 Canada: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
      • 10.1.6.3 Mexico
        • 10.1.6.3.1 Mexico Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.6.3.2 Mexico: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.1.6.3.2.1 Mexico: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.1.6.3.2.2 Mexico: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.1.6.3.3 Mexico: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
        • 10.1.6.3.4 Mexico: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
  • 10.2 Europe Breast Cancer Therapeutics Market, Revenue and Forecast to 2030
    • 10.2.1 Overview
    • 10.2.2 Europe Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
    • 10.2.3 Europe: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
      • 10.2.3.1 Europe: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
      • 10.2.3.2 Europe: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
    • 10.2.4 Europe: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
    • 10.2.5 Europe: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
    • 10.2.6 Europe Breast Cancer Therapeutics Market, by Country
      • 10.2.6.1 UK
        • 10.2.6.1.1 UK Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.6.1.2 UK: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.2.6.1.2.1 UK: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.2.6.1.2.2 UK: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.2.6.1.3 UK: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
        • 10.2.6.1.4 UK: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
      • 10.2.6.2 Germany
        • 10.2.6.2.1 Germany Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.6.2.2 Germany: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.2.6.2.2.1 Germany: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.2.6.2.2.2 Germany: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.2.6.2.3 Germany: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
        • 10.2.6.2.4 Germany: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
      • 10.2.6.3 France
        • 10.2.6.3.1 France Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.6.3.2 France: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.2.6.3.2.1 France: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.2.6.3.2.2 France: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.2.6.3.3 France: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
        • 10.2.6.3.4 France: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
      • 10.2.6.4 Italy
        • 10.2.6.4.1 Italy Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.6.4.2 Italy: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.2.6.4.2.1 Italy: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.2.6.4.2.2 Italy: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.2.6.4.3 Italy: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
        • 10.2.6.4.4 Italy: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
      • 10.2.6.5 Spain
        • 10.2.6.5.1 Spain Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.6.5.2 Spain: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.2.6.5.2.1 Spain: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.2.6.5.2.2 Spain: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.2.6.5.3 Spain: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
        • 10.2.6.5.4 Spain: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
      • 10.2.6.6 Rest of Europe
        • 10.2.6.6.1 Rest of Europe Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.6.6.2 Rest of Europe: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.2.6.6.2.1 Rest of Europe: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.2.6.6.2.2 Rest of Europe: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.2.6.6.3 Rest of Europe: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
        • 10.2.6.6.4 Rest of Europe: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
  • 10.3 Asia Pacific Breast Cancer Therapeutics Market, Revenue and Forecast to 2030
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
    • 10.3.3 Asia Pacific: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
      • 10.3.3.1 Asia Pacific: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
      • 10.3.3.2 Asia Pacific: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
    • 10.3.4 Asia Pacific: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
    • 10.3.5 Asia Pacific: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
    • 10.3.6 Asia Pacific Breast Cancer Therapeutics Market, by Country
      • 10.3.6.1 China
        • 10.3.6.1.1 China Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.6.1.2 China: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.3.6.1.2.1 China: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.3.6.1.2.2 China: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.3.6.1.3 China: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
        • 10.3.6.1.4 China: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
      • 10.3.6.2 Japan
        • 10.3.6.2.1 Japan Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.6.2.2 Japan: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.3.6.2.2.1 Japan: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.3.6.2.2.2 Japan: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.3.6.2.3 Japan: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
        • 10.3.6.2.4 Japan: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
      • 10.3.6.3 India
        • 10.3.6.3.1 India Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.6.3.2 India: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.3.6.3.2.1 India: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.3.6.3.2.2 India: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.3.6.3.3 India: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
        • 10.3.6.3.4 India: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
      • 10.3.6.4 Australia
        • 10.3.6.4.1 Australia Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.6.4.2 Australia: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.3.6.4.2.1 Australia: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.3.6.4.2.2 Australia: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.3.6.4.3 Australia: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
        • 10.3.6.4.4 Australia: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
      • 10.3.6.5 South Korea
        • 10.3.6.5.1 South Korea Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.6.5.2 South Korea: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.3.6.5.2.1 South Korea: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.3.6.5.2.2 South Korea: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.3.6.5.3 South Korea: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
        • 10.3.6.5.4 South Korea: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
      • 10.3.6.6 Rest of Asia Pacific
        • 10.3.6.6.1 Rest of Asia Pacific Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.6.6.2 Rest of Asia Pacific: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.3.6.6.2.1 Rest of Asia Pacific: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.3.6.6.2.2 Rest of Asia Pacific: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.3.6.6.3 Rest of Asia Pacific: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
        • 10.3.6.6.4 Rest of Asia Pacific: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
  • 10.4 Middle East & Africa Breast Cancer Therapeutics Market, Revenue and Forecast to 2030
    • 10.4.1 Overview
    • 10.4.2 Middle East & Africa Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
    • 10.4.3 Middle East & Africa: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
      • 10.4.3.1 Middle East & Africa: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
      • 10.4.3.2 Middle East & Africa: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
    • 10.4.4 Middle East & Africa: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
    • 10.4.5 Middle East & Africa: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
    • 10.4.6 Middle East & Africa Breast Cancer Therapeutics Market, by Country
      • 10.4.6.1 Saudi Arabia
        • 10.4.6.1.1 Saudi Arabia Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.6.1.2 Saudi Arabia: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.4.6.1.2.1 Saudi Arabia: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.4.6.1.2.2 Saudi Arabia: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.4.6.1.3 Saudi Arabia: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
        • 10.4.6.1.4 Saudi Arabia: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
      • 10.4.6.2 UAE
        • 10.4.6.2.1 UAE Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.6.2.2 UAE: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.4.6.2.2.1 UAE: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.4.6.2.2.2 UAE: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.4.6.2.3 UAE: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
        • 10.4.6.2.4 UAE: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
      • 10.4.6.3 South Africa
        • 10.4.6.3.1 South Africa Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.6.3.2 South Africa: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.4.6.3.2.1 South Africa: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.4.6.3.2.2 South Africa: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.4.6.3.3 South Africa: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
        • 10.4.6.3.4 South Africa: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
      • 10.4.6.4 Rest of Middle East & Africa
        • 10.4.6.4.1 Rest of Middle East & Africa Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.6.4.2 Rest of Middle East & Africa: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.4.6.4.2.1 Rest of Middle East & Africa: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.4.6.4.2.2 Rest of Middle East & Africa: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.4.6.4.3 Rest of Middle East & Africa: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
        • 10.4.6.4.4 Rest of Middle East & Africa: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
  • 10.5 South & Central America Breast Cancer Therapeutics Market, Revenue and Forecast to 2030
    • 10.5.1 Overview
    • 10.5.2 South & Central America Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
    • 10.5.3 South & Central America: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
      • 10.5.3.1 South & Central America: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
      • 10.5.3.2 South & Central America: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
    • 10.5.4 South & Central America: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
    • 10.5.5 South & Central America: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
    • 10.5.6 South & Central America Breast Cancer Therapeutics Market, by Country
      • 10.5.6.1 Brazil
        • 10.5.6.1.1 Brazil Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.5.6.1.2 Brazil: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.5.6.1.2.1 Brazil: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.5.6.1.2.2 Brazil: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.5.6.1.3 Brazil: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
        • 10.5.6.1.4 Brazil: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
      • 10.5.6.2 Argentina
        • 10.5.6.2.1 Argentina Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.5.6.2.2 Argentina: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.5.6.2.2.1 Argentina: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.5.6.2.2.2 Argentina: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.5.6.2.3 Argentina: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
        • 10.5.6.2.4 Argentina: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)
      • 10.5.6.3 Rest of South & Central America
        • 10.5.6.3.1 Rest of South & Central America Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.5.6.3.2 Rest of South & Central America: Breast Cancer Therapeutics Market, by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.5.6.3.2.1 Rest of South & Central America: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.5.6.3.2.2 Rest of South & Central America: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020 - 2030 (US$ Million)
        • 10.5.6.3.3 Rest of South & Central America: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020 - 2030 (US$ Million)
        • 10.5.6.3.4 Rest of South & Central America: Breast Cancer Therapeutics Market, by Distribution Channel, 2020 - 2030 (US$ Million)

11. Breast Cancer Therapeutics Market ??Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Breast Cancer Therapeutics Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Eli Lilly and Co
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Eisai Co Ltd
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Novartis AG
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 AstraZeneca Plc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Pfizer Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Gilead Sciences Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Merck & Co Inc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Genentech Inc.
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Teva Pharmaceutical Industries Ltd
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Amgen Inc
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Breast Cancer Therapeutics Market Segmentation
  • Table 2. Global Breast Cancer Therapeutics Market, by Targeted Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 3. Global Breast Cancer Therapeutics Market, by Hormonal Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 4. North America Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 5. North America Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 6. North America Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 7. North America Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 8. North America Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 9. US Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 10. US Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 11. US Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 12. US Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 13. US Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Canada Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Canada Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Canada Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Canada Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Canada Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Mexico Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Mexico Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 21. Mexico Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Mexico Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 23. Mexico Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 24. Europe Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 25. Europe Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 26. Europe Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 27. Europe Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 28. Europe Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 29. UK Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 30. UK Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 31. UK Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 32. UK Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 33. UK Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 34. Germany Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 35. Germany Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 36. Germany Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 37. Germany Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 38. Germany Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 39. France Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 40. France Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 41. France Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 42. France Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 43. France Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 44. Italy Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 45. Italy Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 46. Italy Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 47. Italy Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 48. Italy Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 49. Spain Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 50. Spain Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 51. Spain Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 52. Spain Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 53. Spain Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 54. Rest of Europe Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 55. Rest of Europe Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 56. Rest of Europe Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 57. Rest of Europe Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 58. Rest of Europe Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 59. Asia Pacific Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 60. Asia Pacific Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 61. Asia Pacific Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 62. Asia Pacific Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 63. Asia Pacific Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 64. China Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 65. China Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 66. China Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 67. China Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 68. China Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 69. Japan Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 70. Japan Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 71. Japan Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 72. Japan Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 73. Japan Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 74. India Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 75. India Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 76. India Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 77. India Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 78. India Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 79. Australia Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 80. Australia Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 81. Australia Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 82. Australia Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 83. Australia Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 84. South Korea Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 85. South Korea Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 86. South Korea Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 87. South Korea Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 88. South Korea Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 89. Rest of Asia Pacific Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 90. Rest of Asia Pacific Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 91. Rest of Asia Pacific Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 92. Rest of Asia Pacific Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 93. Rest of Asia Pacific Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 94. Middle East & Africa Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 95. Middle East & Africa Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 96. Middle East & Africa Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 97. Middle East & Africa Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 98. Middle East & Africa Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 99. Saudi Arabia Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 100. Saudi Arabia Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 101. Saudi Arabia Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 102. Saudi Arabia Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 103. Saudi Arabia Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 104. UAE Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 105. UAE Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 106. UAE Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 107. UAE Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 108. UAE Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 109. South Africa Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 110. South Africa Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 111. South Africa Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 112. South Africa Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 113. South Africa Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 114. Rest of Middle East & Africa Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 115. Rest of Middle East & Africa Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 116. Rest of Middle East & Africa Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 117. Rest of Middle East & Africa Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 118. Rest of Middle East & Africa Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 119. South & Central America Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 120. South & Central America Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 121. South & Central America Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 122. South & Central America Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 123. South & Central America Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 124. Brazil Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 125. Brazil Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 126. Brazil Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 127. Brazil Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 128. Brazil Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 129. Argentina Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 130. Argentina Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 131. Argentina Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 132. Argentina Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 133. Argentina Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 134. Rest of South & Central America Breast Cancer Therapeutics Market, by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 135. Rest of South & Central America Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 136. Rest of South & Central America Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy Revenue and Forecast to 2030 (US$ Million)
  • Table 137. Rest of South & Central America Breast Cancer Therapeutics Market, by Breast Cancer Type Revenue and Forecast to 2030 (US$ Million)
  • Table 138. Rest of South & Central America Breast Cancer Therapeutics Market, by Distribution Channel Revenue and Forecast to 2030 (US$ Million)
  • Table 139. Recent Organic Growth Strategies in Breast Cancer Therapeutics Market
  • Table 140. Recent Inorganic Growth Strategies in the Breast Cancer Therapeutics Market
  • Table 141. Glossary of Terms, Breast Cancer Therapeutics Market

List Of Figures

  • Figure 1. Breast Cancer Therapeutics Market Segmentation, By Geography
  • Figure 2. Global - PEST Analysis
  • Figure 3. Breast Cancer Therapeutics Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Breast Cancer Therapeutics Market Revenue (US$ Mn), 2022 2030
  • Figure 6. Breast Cancer Therapeutics Market Revenue Share, by Drug Therapy, 2022 & 2030 (%)
  • Figure 7. Targeted Drug Therapy: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Hormonal Drug Therapy: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Chemotherapy: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Immunotherapy/ Biological Therapy: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Breast Cancer Therapeutics Market Revenue Share, by Breast Cancer Type, 2022 & 2030 (%)
  • Figure 12. Hormone Receptor: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. HER2+: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Triple-Negative Breast Cancer: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Breast Cancer Therapeutics Market Revenue Share, by Distribution Channel, 2022 & 2030 (%)
  • Figure 16. Hospital Pharmacies: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Drug Store and Retail Pharmacies: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Online Pharmacies: Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. North America: Breast Cancer Therapeutics Market, by Key Country Revenue (2022) (US$ Million)
  • Figure 20. North America Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 21. North America Breast Cancer Therapeutics Market, By Key Countries, 2022 and 2030 (%)
  • Figure 22. US Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 23. Canada Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 24. Mexico Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 25. Europe Breast Cancer Therapeutics Market, by Key Country Revenue, 2022 (US$ Million)
  • Figure 26. Europe Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. Europe Breast Cancer Therapeutics Market, By Key Countries, 2022 and 2030 (%)
  • Figure 28. UK Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 29. Germany Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 30. France Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 31. Italy Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 32. Spain Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 33. Rest of Europe Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 34. Asia Pacific Breast Cancer Therapeutics Market, by Key Country Revenue, 2022 (US$ Million)
  • Figure 35. Asia Pacific Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 36. Asia Pacific Breast Cancer Therapeutics Market, By Key Countries, 2022 and 2030 (%)
  • Figure 37. China Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 38. Japan Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 39. India Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 40. Australia Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 41. South Korea Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 42. Rest of Asia Pacific Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 43. Middle East & Africa Breast Cancer Therapeutics Market, by Key Country Revenue, 2022 (US$ Million)
  • Figure 44. Middle East & Africa Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 45. Middle East & Africa Breast Cancer Therapeutics Market, By Key Countries, 2022 and 2030 (%)
  • Figure 46. Saudi Arabia Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 47. UAE Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 48. South Africa Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 49. Rest of Middle East & Africa Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 50. South & Central America Breast Cancer Therapeutics Market, by Key Country Revenue, 2022 (US$ Million)
  • Figure 51. South & Central America Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 52. South & Central America Breast Cancer Therapeutics Market, By Key Countries, 2022 and 2030 (%)
  • Figure 53. Brazil Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 54. Argentina Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 55. Rest of South & Central America Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 56. Growth Strategies in Breast Cancer Therapeutics Market